LFTD Partners Inc. Reports Q1 2026 Financial Results with Increased Net Loss and Rising Costs

LFTD Partners Inc. reported its financial results for the first quarter of 2026, revealing a net sales figure of $9.16 million, a slight increase from $9.12 million in the same period of 2025. However, the company experienced a significant increase in its cost of goods sold, which rose to $10.86 million from $6.91 million year-over-year, resulting in a gross loss of $1.71 million compared to a gross profit of $2.22 million in the prior year. The net loss attributable to common stockholders for the quarter was $4.16 million, or $(0.28) per share, compared to a loss of $306,373, or $(0.02) per share, in the first quarter of 2025.

The financial performance reflects a notable shift in operational dynamics, particularly in the cost structure. The increase in cost of goods sold was attributed to several factors, including a substantial inventory reserve of $5.06 million established against hemp-derived products, which was not present in the previous year. This reserve was influenced by regulatory uncertainties surrounding the hemp industry, particularly the potential national ban on intoxicating hemp-derived consumables set to take effect in November 2026. Additionally, the company recorded an impairment charge of $143,421 against its hemp-specific fixed assets, further impacting profitability.

Operationally, LFTD Partners has maintained a steady customer base, with total accounts receivable reported at $2.25 million as of March 31, 2026, down from $2.53 million at the end of 2025. The company’s inventory also saw a significant reduction, totaling $5.53 million compared to $10.96 million at the end of the previous fiscal year, reflecting a strategic shift in inventory management amid changing market conditions. The company continues to focus on its core brands, including Lifted Made and Urb, while also exploring opportunities for geographic expansion and product diversification.

Looking ahead, LFTD Partners has expressed caution regarding its future operations, particularly in light of the regulatory landscape affecting the hemp industry. The company is actively monitoring market conditions and customer demand, especially as it relates to its hemp-derived product lines. Management has indicated that it will continue to assess its inventory levels and may adjust its operational strategies to mitigate risks associated with potential regulatory changes. The company remains committed to exploring acquisitions outside the hemp sector to diversify its portfolio and reduce exposure to regulatory risks inherent in the cannabis industry.